Christiana Stamoulis
SVP, Corp Strategy & Bus Devlp, Vertex Pharmaceuticals.
Companies
- Keenova Therapeutics plcChief financial officer Sep 25, 2025 to now1
- Keenova Therapeutics plcPresident Sep 25, 2025 to now1
- HologicBoard member Nov 3, 2011 to now2
- IncyteChief financial officer Feb 13, 2019 to May 6, 20263
- Cogent Biosciences, Inc.President Mar 28, 2018 to Mar 28, 20184
- Vertex PharmaceuticalsSVP, Corp Strategy & Bus Devlp Oct 14, 2010 to Aug 1, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Incyte INCY125,759 shares6$14.3M at $113.77Jul 15, 2025
Hologic HOLX0 shares7Apr 7, 2026- Keenova Therapeutics plc17,828 shares8Dec 19, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 7, 2026Returned to company 50,526 shares of Hologic7
- Feb 26, 2026Granted 3,190 shares of Hologic9
- Dec 19, 2025Shares withheld for tax 18,631 shares of Keenova Therapeutics plc8
- Dec 15, 2025Exercised options 30,335 shares of Keenova Therapeutics plc10
- Oct 20, 2025Sold 7,402 shares at $73.07 of Hologic11
- Oct 20, 2025Exercised options 7,402 shares at $36.04 of Hologic11
- Jul 15, 2025Granted 11,107 shares of Incyte6
- Jul 15, 2025Shares withheld for tax 1,445 shares at $68.25 of Incyte6
- Jul 14, 2025Shares withheld for tax 1,407 shares at $69.98 of Incyte6
- Jul 2, 2025Shares withheld for tax 11,589 shares at $68.17 of Incyte12
- Apr 1, 2025Granted 18,970 shares of Incyte13
- Apr 1, 2025Granted 18,598 shares of Incyte13
- Feb 26, 2025Granted 1,864 shares of Hologic14
- Jan 15, 2025Shares withheld for tax 3,672 shares at $72.46 of Incyte15
- Jul 17, 2024Sold 9,039 shares at $79.50 of Hologic16
- Jul 17, 2024Exercised options 9,039 shares at $26.74 of Hologic16
- Jul 15, 2024Shares withheld for tax 948 shares at $64.25 of Incyte17
- Jul 15, 2024Granted 12,572 shares of Incyte17
- Jul 2, 2024Shares withheld for tax 6,870 shares at $59.02 of Incyte18
- Mar 7, 2024Granted 1,572 shares of Hologic19
- Feb 14, 2024Granted 7,377 shares of Incyte20
- Feb 12, 2024Shares withheld for tax 387 shares at $57.84 of Incyte21
- Jul 14, 2023Granted 12,246 shares of Incyte22
- Jul 3, 2023Shares withheld for tax 6,073 shares at $62.08 of Incyte23
- Mar 9, 2023Granted 1,465 shares of Hologic24
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARHologic, Board member
- 3SEC EDGARIncyte, Chief financial officer
- 4SEC EDGARCogent Biosciences, Inc., President
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Mar 2, 2026
- 10SEC EDGARForm 4 filed Dec 17, 2025
- 11SEC EDGARForm 4 filed Oct 22, 2025
- 12SEC EDGARForm 4 filed Jul 7, 2025
- 13SEC EDGARForm 4 filed Apr 3, 2025
- 14SEC EDGARForm 4 filed Feb 28, 2025
- 15SEC EDGARForm 4 filed Jan 17, 2025
- 16SEC EDGARForm 4 filed Jul 19, 2024
- 17SEC EDGARForm 4 filed Jul 17, 2024
- 18SEC EDGARForm 4 filed Jul 3, 2024
- 19SEC EDGARForm 4 filed Mar 11, 2024
- 20SEC EDGARForm 4 filed Feb 16, 2024
- 21SEC EDGARForm 4 filed Feb 14, 2024
- 22SEC EDGARForm 4 filed Jul 18, 2023
- 23SEC EDGARForm 4 filed Jul 6, 2023
- 24SEC EDGARForm 4 filed Mar 13, 2023